4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000033
Chief Medical Officer sold 2,171 shares at $30.30 ($65,781)
- Chief Medical Officer acquired 2,171 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-07-09 | Option exercise 10b5-1 | +2,171 | $16.00 | $34,736 | 59,904 | D |
| Rodman David Malcom Chief Medical Officer | 2026-07-09 | Sale 10b5-1 | −2,171 | $30.30 | $65,781 | 57,733 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-07-09 | Option exercise · Stock Option 10b5-1 | −2,171 | 15,194 | D | ||
| Open-market sales · 2,171 sh · avg $30.30 · $65,781 | |||||||
Loading xslF345X06/wk-form4_1783725320.xml…